Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. more
Time Frame | TNDM | Sector | S&P500 |
---|---|---|---|
1-Week Return | 13.35% | -2.82% | 0.15% |
1-Month Return | 10.32% | -4.22% | 1.78% |
3-Month Return | -21.6% | -9.52% | 8.7% |
6-Month Return | -27.54% | -3.45% | 12.24% |
1-Year Return | 44.77% | 5.62% | 30.9% |
3-Year Return | -74.16% | 3.8% | 30.19% |
5-Year Return | -40.53% | 39.68% | 91.72% |
10-Year Return | -70.32% | 105.02% | 203.2% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 362.31M | 498.83M | 702.80M | 801.22M | 747.72M | [{"date":"2019-12-31","value":45.22,"profit":true},{"date":"2020-12-31","value":62.26,"profit":true},{"date":"2021-12-31","value":87.72,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.32,"profit":true}] |
Cost of Revenue | 168.09M | 238.31M | 326.58M | 388.23M | 380.03M | [{"date":"2019-12-31","value":43.3,"profit":true},{"date":"2020-12-31","value":61.38,"profit":true},{"date":"2021-12-31","value":84.12,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.89,"profit":true}] |
Gross Profit | 194.21M | 260.52M | 376.21M | 412.99M | 367.69M | [{"date":"2019-12-31","value":47.03,"profit":true},{"date":"2020-12-31","value":63.08,"profit":true},{"date":"2021-12-31","value":91.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.03,"profit":true}] |
Gross Margin | 53.60% | 52.23% | 53.53% | 51.54% | 49.17% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":97.43,"profit":true},{"date":"2021-12-31","value":99.86,"profit":true},{"date":"2022-12-31","value":96.16,"profit":true},{"date":"2023-12-31","value":91.74,"profit":true}] |
Operating Expenses | 210.93M | 268.48M | 353.56M | 474.80M | 600.92M | [{"date":"2019-12-31","value":35.1,"profit":true},{"date":"2020-12-31","value":44.68,"profit":true},{"date":"2021-12-31","value":58.84,"profit":true},{"date":"2022-12-31","value":79.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (16.72M) | (7.96M) | 8.81M | (61.81M) | (233.23M) | [{"date":"2019-12-31","value":-189.85,"profit":false},{"date":"2020-12-31","value":-90.34,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-701.74,"profit":false},{"date":"2023-12-31","value":-2647.93,"profit":false}] |
Total Non-Operating Income/Expense | (4.69M) | (39.56M) | (12.12M) | (156.00K) | 25.95M | [{"date":"2019-12-31","value":-18.07,"profit":false},{"date":"2020-12-31","value":-152.45,"profit":false},{"date":"2021-12-31","value":-46.69,"profit":false},{"date":"2022-12-31","value":-0.6,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (24.60M) | (36.28M) | 15.90M | (92.85M) | (220.25M) | [{"date":"2019-12-31","value":-154.73,"profit":false},{"date":"2020-12-31","value":-228.17,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-583.94,"profit":false},{"date":"2023-12-31","value":-1385.16,"profit":false}] |
Income Taxes | 149.00K | (1.90M) | 335.00K | 1.74M | 2.36M | [{"date":"2019-12-31","value":6.32,"profit":true},{"date":"2020-12-31","value":-80.61,"profit":false},{"date":"2021-12-31","value":14.21,"profit":true},{"date":"2022-12-31","value":73.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (24.75M) | (34.38M) | 15.57M | (94.59M) | (222.61M) | [{"date":"2019-12-31","value":-159.02,"profit":false},{"date":"2020-12-31","value":-220.88,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-607.7,"profit":false},{"date":"2023-12-31","value":-1430.11,"profit":false}] |
Income From Continuous Operations | (24.75M) | (34.38M) | 15.57M | (94.59M) | (222.61M) | [{"date":"2019-12-31","value":-159.02,"profit":false},{"date":"2020-12-31","value":-220.88,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-607.7,"profit":false},{"date":"2023-12-31","value":-1430.11,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (24.75M) | (34.38M) | 15.57M | (94.59M) | (222.61M) | [{"date":"2019-12-31","value":-159.02,"profit":false},{"date":"2020-12-31","value":-220.88,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-607.7,"profit":false},{"date":"2023-12-31","value":-1430.11,"profit":false}] |
EPS (Diluted) | (0.44) | (0.63) | 0.23 | (0.99) | (3.12) | [{"date":"2019-12-31","value":-191.3,"profit":false},{"date":"2020-12-31","value":-273.91,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-430.43,"profit":false},{"date":"2023-12-31","value":-1356.52,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
TNDM | |
---|---|
Cash Ratio | 1.83 |
Current Ratio | 2.90 |
Quick Ratio | 2.32 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TNDM | |
---|---|
ROA (LTM) | -9.69% |
ROE (LTM) | -45.96% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TNDM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.75 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.25 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TNDM | |
---|---|
Trailing PE | NM |
Forward PE | 1111.11 |
P/S (TTM) | 2.60 |
P/B | 9.34 |
Price/FCF | 103 |
EV/R | 2.60 |
EV/Ebitda | NM |
PEG | NM |
Tandem Diabetes Care Inc (TNDM) share price today is $34.31
Yes, Indians can buy shares of Tandem Diabetes Care Inc (TNDM) on Vested. To buy Tandem Diabetes Care Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TNDM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Tandem Diabetes Care Inc (TNDM) via the Vested app. You can start investing in Tandem Diabetes Care Inc (TNDM) with a minimum investment of $1.
You can invest in shares of Tandem Diabetes Care Inc (TNDM) via Vested in three simple steps:
The 52-week high price of Tandem Diabetes Care Inc (TNDM) is $53.69. The 52-week low price of Tandem Diabetes Care Inc (TNDM) is $21.85.
The price-to-earnings (P/E) ratio of Tandem Diabetes Care Inc (TNDM) is
The price-to-book (P/B) ratio of Tandem Diabetes Care Inc (TNDM) is 9.34
The dividend yield of Tandem Diabetes Care Inc (TNDM) is 0.00%
The market capitalization of Tandem Diabetes Care Inc (TNDM) is $2.22B
The stock symbol (or ticker) of Tandem Diabetes Care Inc is TNDM